Item 9 Labs CorpOver The Counter Market:INLB
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | INLB |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Item 9 Labs Corp | 10.2K | 0.0x | --- |
Signature Eyewear Inc | 10.0 | 0.0x | -26.18% |
Biocept Inc | 260.0 | 0.0x | --- |
Fuse Medical Inc | 7.3M | 2.7x | +2.06% |
Acutus Medical Inc | 5.0M | -0.2x | --- |
Applied DNA Sciences Inc | 4.1M | -8.2x | --- |
Company Information
Item 9 Labs Corp. is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The Company also offers a dispensary franchise model through the national Unity Rd. retail brand. The Company offers approximately 75 active cannabis strains and more than 150 differentiated cannabis vaporizer (vape) products, as well as premium concentrates and Orion vape technologies. The Company's Item 9 Labs brand specializes in select products and user experience across several cannabis categories. The Company operates through two segments: Cultivation and Franchising. Its product lines include Item 9 Labs Flower, Item 9 Labs Concentrates, and Orion 710.
Contact Information
- Headquarters
- 2111 E HIGHLAND AVE, SUITE B375PHOENIX, AZ, United States 85016
- Phone
- 480-463-4246
- Fax
- 302-658-3694
Executives
- Chief Operating Officer
- Christopher Wolven
- Independent Director
- Eric Kutscher
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.2K |
|---|---|
Revenue (TTM) | $19.7M |
Shares Outstanding | 102.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.83 |
EPS | $-0.32 |
Book Value | $0.63 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -110.94% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
